How to purchase evantuzumab officially in the country

Evantumumab (amivantamab) is a bispecific antibody targeting the epidermal growth factor receptor (EGFR) and the MET receptor. It is mainly used to treat certain types of non-small cell lung cancer (NSCLC). The drug will be launched in China in early 2025, bringing new treatment hope to many patients with advanced and metastatic lung cancer. However, due to its short time on the market, domestic patients may face difficulties in purchasing it directly.

For patients who wish to use evantumumab, they may consider obtaining it through overseas channels. Evantumumab has been approved and marketed in some countries, such as the United States and the European Union. Overseas versions of drugs are usually called original drugs, and their specifications are mostly 350mg. The price of each box is about 20,000 yuan. This price will change due to exchange rate fluctuations. Although the price of the overseas version is relatively high compared with domestic drug prices, its effectiveness and safety are internationally recognized, and many patients are still willing to choose this treatment option.

When purchasing evantumumab in China, patients can consult local hospitals or pharmacies to find out whether there is a supply of related drugs. In addition, you can also ask professional medical institutions or drug procurement platforms for access channels. Some patients also choose to import drugs from overseas through overseas shopping or purchasing on behalf of others. This requires attention to choosing a reputable platform to ensure the authenticity and effectiveness of the drugs.

It should be emphasized that patients must undergo detailed medical evaluation and genetic testing to confirm their indications before using evantumumab. The effect of this targeted therapy is often closely related to the patient's specific genetic mutation status, so the guidance of professional doctors is crucial. At the same time, while using evantumumab, patients should pay attention to monitoring adverse reactions and drug interactions, communicate with doctors in a timely manner, and adjust treatment plans to ensure the best treatment effect.

Reference materials:https://www.rybrevant.com/